Oryzon Genomics announced by means of a "relevant fact" to the CNMV changes on its corporate governing bodies. The company has incorporated February 19, 2018 to Oryzon Genomics' Board of Directors Dr. José Carlos Gutiérrez-Ramos, President and CEO of Synlogic Inc. as Independent Director. Dr. Gutiérrez-Ramos is a key addition for the company in its expansion plans in the US market. In the same meeting of the Board held February 19th, the resignation of the three Directors representing NAJETI has been tendered. After this revamp, Oryzon's Board of Directors is composed of seven Directors, of which four are independent Directors.